CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

B. Riley Adjusts Capricor Therapeutics Price Target to $5 From $10, Maintains Neutral Rating

Negative
AI Analysis

Summary

B. Riley reduced its price target for Capricor Therapeutics from $10 to $5 while maintaining a neutral rating, indicating a significant valuation reduction.

Importance:2/10
Sentiment:
-0.60
price_target_adjustmentanalyst_downgradevaluation
Related Companies

Read the original article

Published by yahoo_finance on July 31, 2026 1:37 PM

Read Original